SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-24-085129
Filing Date
2024-04-02
Accepted
2024-04-02 20:43:55
Documents
1
Group Members
ATHYRIUM FUNDS GP HOLDINGS LLCATHYRIUM OPPORTUNITIES ASSOCIATES CO-INVEST LLCATHYRIUM OPPORTUNITIES ASSOCIATES III GP LLCATHYRIUM OPPORTUNITIES ASSOCIATES III LPATHYRIUM OPPORTUNITIES III ACQUISITION 2 LPATHYRIUM OPPORTUNITIES III ACQUISITION LPATHYRIUM O

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d811206dsc13da.htm SC 13D/A 222430
  Complete submission text file 0001193125-24-085129.txt   224652
Mailing Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122
Business Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122 855-293-2639
BIORA THERAPEUTICS, INC. (Subject) CIK: 0001580063 (see all company filings)

IRS No.: 273950390 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91551 | Film No.: 24816614
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 505 FIFTH AVENUE, FLOOR 18 NEW YORK NY 10017
Business Address 505 FIFTH AVENUE, FLOOR 18 NEW YORK NY 10017 646-434-1636
Athyrium Opportunities 2020 LP (Filed by) CIK: 0001815261 (see all company filings)

IRS No.: 850719033 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A